- Home
- Publications
- Publication Search
- Publication Details
Title
HDL Proteome and Alzheimer’s Disease: Evidence of a Link
Authors
Keywords
-
Journal
Antioxidants
Volume 9, Issue 12, Pages 1224
Publisher
MDPI AG
Online
2020-12-04
DOI
10.3390/antiox9121224
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Development, optimization and validation of an absolute specific assay for active myeloperoxidase (MPO) and its application in a clinical context: role of MPO specific activity in coronary artery disease
- (2020) Alessandro Trentini et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Advances in HDL: Much More than Lipid Transporters
- (2020) Soumaya Ben-Aicha et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Paraoxonase 1 decline and lipid peroxidation rise reflect a degree of brain atrophy and vascular impairment in dementia
- (2020) Iwona Bednarz-Misa et al. Advances in Clinical and Experimental Medicine
- Lecithin:Cholesterol Acyltransferase: Symposium on 50-years of biomedical research from its discovery to latest findings
- (2020) Kaare R Norum et al. JOURNAL OF LIPID RESEARCH
- The Positive Side of the Alzheimer’s Disease Amyloid Cross-Interactions: The Case of the Aβ 1-42 Peptide with Tau, TTR, CysC, and ApoA1
- (2020) Lidia Ciccone et al. MOLECULES
- APOE4 leads to blood–brain barrier dysfunction predicting cognitive decline
- (2020) Axel Montagne et al. NATURE
- Molecular Insight into the Therapeutic Promise of Targeting APOE4 for Alzheimer’s Disease
- (2020) Abdullah Al Mamun et al. Oxidative Medicine and Cellular Longevity
- The Important Interface Between Apolipoprotein E and Neuroinflammation in Alzheimer’s Disease
- (2020) Courtney M. Kloske et al. Frontiers in Immunology
- Arylesterase Activity of Paraoxonase-1 in Serum and Cerebrospinal Fluid of Patients with Alzheimer’s Disease and Vascular Dementia
- (2020) Arianna Romani et al. Antioxidants
- Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor exerts greater efficacy than atorvastatin on improvement of brain function and cognition in obese rats
- (2020) Busarin Arunsak et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- 25-Hydroxycholesterol amplifies microglial IL-1β production in an apoE isoform-dependent manner
- (2020) Man Ying Wong et al. Journal of Neuroinflammation
- APOE in Alzheimer's disease and neurodegeneration
- (2020) D. Allan Butterfield et al. NEUROBIOLOGY OF DISEASE
- Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) in the Brain and Relevance for Neuropsychiatric Disorders
- (2020) Emma M. O’Connell et al. Frontiers in Neuroscience
- Exploring the Role of CLU in the Pathogenesis of Alzheimer’s Disease
- (2020) Md. Sahab Uddin et al. NEUROTOXICITY RESEARCH
- Fragmentation of brain apolipoprotein E (ApoE) and its relevance in Alzheimer's disease
- (2020) Asiamah Ernest Amponsah et al. REVIEWS IN THE NEUROSCIENCES
- APOE4-mediated amyloid-β pathology depends on its neuronal receptor LRP1
- (2019) Masaya Tachibana et al. JOURNAL OF CLINICAL INVESTIGATION
- Neuronal apolipoprotein E4 increases cell death and phosphorylated tau release in alzheimer disease
- (2019) Anil R. Wadhwani et al. ANNALS OF NEUROLOGY
- Apolipoprotein A-I Crosses the Blood-Brain Barrier through Clathrin-Independent and Cholesterol-Mediated Endocytosis
- (2019) Andrew L. Zhou et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Evaluating the link between Paraoxonase-1 levels and Alzheimer's disease development
- (2019) Carlo Cervellati et al. MINERVA MEDICA
- Knockout of apolipoprotein A‐I decreases parenchymal and vascular β‐amyloid pathology in the Tg2576 mouse model of Alzheimer's disease
- (2019) L. Contu et al. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
- Peripheral administration of human recombinant ApoJ/clusterin modulates brain beta-amyloid levels in APP23 mice
- (2019) Sofía Fernández de Retana et al. Alzheimers Research & Therapy
- ApoA-I deficiency increases cortical amyloid deposition, cerebral amyloid angiopathy, cortical and hippocampal astrogliosis, and amyloid-associated astrocyte reactivity in APP/PS1 mice
- (2019) Emily B. Button et al. Alzheimers Research & Therapy
- The Extent of Human Apolipoprotein A-I Lipidation Strongly Affects the β-Amyloid Efflux Across the Blood-Brain Barrier in vitro
- (2019) Roberta Dal Magro et al. Frontiers in Neuroscience
- APOA1 oxidation is associated to dysfunctional high-density lipoproteins in human abdominal aortic aneurysm
- (2019) Diego Martínez-López et al. EBioMedicine
- Paraoxonase-1 activities in individuals with different HDL circulating levels: Implication in reverse cholesterol transport and early vascular damage
- (2019) Carlo Cervellati et al. ATHEROSCLEROSIS
- HDL from an Alzheimerʼs disease perspective
- (2019) Emily B. Button et al. CURRENT OPINION IN LIPIDOLOGY
- High-Density Lipoproteins Decrease Proinflammatory Activity and Modulate the Innate Immune Response
- (2019) Natalia A. Taborda et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- ABCA1- and ABCG1-mediated cholesterol efflux capacity of cerebrospinal fluid is impaired in Alzheimer’s disease
- (2019) Cinzia Marchi et al. JOURNAL OF LIPID RESEARCH
- Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategies
- (2019) Yu Yamazaki et al. Nature Reviews Neurology
- Peripheral versus central nervous system APOE in Alzheimer’s disease: Interplay across the blood-brain barrier
- (2019) Dustin Chernick et al. NEUROSCIENCE LETTERS
- Proprotein convertase subtilisin/kexin type 9 (PCSK9) in Alzheimer’s disease: A genetic and proteomic multi-cohort study
- (2019) Cynthia Picard et al. PLoS One
- ApoE4 Alters ABCA1 Membrane Trafficking in Astrocytes
- (2019) Varun Rawat et al. JOURNAL OF NEUROSCIENCE
- Intracellular and secreted forms of clusterin are elevated early in Alzheimer's disease and associate with both Aβ and tau pathology
- (2019) Claire E. Shepherd et al. NEUROBIOLOGY OF AGING
- Intraventricular infusion of clusterin ameliorated cognition and pathology in Tg6799 model of Alzheimer’s disease
- (2018) Xue-Mei Qi et al. BMC NEUROSCIENCE
- Alterations in cholesterol metabolism–related genes in sporadic Alzheimer's disease
- (2018) Cynthia Picard et al. NEUROBIOLOGY OF AGING
- Genetic variation in clusterin and risk of dementia and ischemic vascular disease in the general population - cohort studies and meta-analyses of 362,338 individuals
- (2018) L.T. Nordestgaard et al. ATHEROSCLEROSIS
- Understanding the Role of ApoE Fragments in Alzheimer’s Disease
- (2018) Sonia Sanz Muñoz et al. NEUROCHEMICAL RESEARCH
- Association between clusterin concentration and dementia: a systematic review and meta-analysis
- (2018) Caiping Yang et al. METABOLIC BRAIN DISEASE
- Reduced Cerebrospinal Fluid Concentration of Apolipoprotein A-I in Patients with Alzheimer’s Disease
- (2017) Per Johansson et al. JOURNAL OF ALZHEIMERS DISEASE
- Apolipoprotein A1 in Cerebrospinal Fluid and Plasma and Progression to Alzheimer’s Disease in Non-Demented Elderly
- (2017) Rosalinde E.R. Slot et al. JOURNAL OF ALZHEIMERS DISEASE
- Apolipoprotein E4 Elicits Lysosomal Cathepsin D Release, Decreased Thioredoxin-1 Levels, and Apoptosis
- (2017) Torbjörn Persson et al. JOURNAL OF ALZHEIMERS DISEASE
- A Meta-Analysis on the Relationship of the PON Genes and Alzheimer Disease
- (2017) Yi Nie et al. JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY
- ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy
- (2017) Yang Shi et al. NATURE
- Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease
- (2017) A. Michael Lincoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- SR-BI Mediated Transcytosis of HDL in Brain Microvascular Endothelial Cells Is Independent of Caveolin, Clathrin, and PDZK1
- (2017) Karen Y. Fung et al. Frontiers in Physiology
- Central Nervous System LipoproteinsHighlights
- (2016) Robert W. Mahley ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Serum paraoxonase-1 activity and risk of incident cardiovascular disease: The PREVEND study and meta-analysis of prospective population studies
- (2016) Setor K. Kunutsor et al. ATHEROSCLEROSIS
- Paraoxonases-1, -2 and -3: What are their functions?
- (2016) Clement E. Furlong et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Oxidative signature of cerebrospinal fluid from mild cognitive impairment and Alzheimer disease patients
- (2016) Fabio Di Domenico et al. FREE RADICAL BIOLOGY AND MEDICINE
- Decreased arylesterase activity of paraoxonase-1 (PON-1) might be a common denominator of neuroinflammatory and neurodegenerative diseases
- (2016) Massimiliano Castellazzi et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Modulation of Amyloid-β1–40 Transport by ApoA1 and ApoJ Across an in vitro Model of the Blood-Brain Barrier
- (2016) Cristina Merino-Zamorano et al. JOURNAL OF ALZHEIMERS DISEASE
- Increased PCSK9 Cerebrospinal Fluid Concentrations in Alzheimer’s Disease
- (2016) Francesca Zimetti et al. JOURNAL OF ALZHEIMERS DISEASE
- Apolipoprotein E Genotype Affects Size of ApoE Complexes in Cerebrospinal Fluid
- (2016) Nicolette Mary Heinsinger et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Association of APOE with tau-tangle pathology with and without β-amyloid
- (2016) Jose M. Farfel et al. NEUROBIOLOGY OF AGING
- Effect of CLU genetic variants on cerebrospinal fluid and neuroimaging markers in healthy, mild cognitive impairment and Alzheimer’s disease cohorts
- (2016) Lin Tan et al. Scientific Reports
- Recent global trends in the prevalence and incidence of dementia, and survival with dementia
- (2016) Martin Prince et al. Alzheimers Research & Therapy
- PON-1 and ferroxidase activities in older patients with mild cognitive impairment, late onset Alzheimer’s disease or vascular dementia
- (2015) Carlo Cervellati et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Dysfunctional HDL and atherosclerotic cardiovascular disease
- (2015) Robert S. Rosenson et al. Nature Reviews Cardiology
- Proteomic and lipidomic analyses of paraoxonase defined high density lipoprotein particles: Association of paraoxonase with the anti-coagulant, protein S
- (2015) Xenia Moren et al. Proteomics Clinical Applications
- Rare Individual Amyloid-β Oligomers Act on Astrocytes to Initiate Neuronal Damage
- (2014) Priyanka Narayan et al. BIOCHEMISTRY
- The overlap between vascular disease and Alzheimer’s disease - lessons from pathology
- (2014) Johannes Attems et al. BMC Medicine
- HDL and cholesterol handling in the brain
- (2014) C. Vitali et al. CARDIOVASCULAR RESEARCH
- HDL Cholesterol Efflux Capacity and Incident Cardiovascular Events
- (2014) Anand Rohatgi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Flow-mediated dilation, carotid wall thickness and HDL function in subjects with hyperalphalipoproteinemia
- (2014) G.B. Vigna et al. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
- Transthyretin suppresses the toxicity of oligomers formed by misfolded proteins in vitro
- (2013) Roberta Cascella et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Original article Paraoxonase 1 (PON1) gene -108C>T and p.Q192R polymorphisms and arylesterase activity of the enzyme in patients with dementia
- (2013) Małgorzata Ewa Bednarska-Makaruk et al. FOLIA NEUROPATHOLOGICA
- Myeloperoxidase, paraoxonase-1, and HDL form a functional ternary complex
- (2013) Ying Huang et al. JOURNAL OF CLINICAL INVESTIGATION
- ApoE influences amyloid- (A ) clearance despite minimal apoE/A association in physiological conditions
- (2013) P. B. Verghese et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Paraoxonase 1 in neurological disorders
- (2013) Teresita Menini et al. REDOX REPORT
- What are lipoproteins doing in the brain?
- (2013) Hong Wang et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- RVX 208
- (2013) Drugs in research & development
- Neurovascular Dysfunction and Faulty Amyloid -Peptide Clearance in Alzheimer Disease
- (2013) A. P. Sagare et al. Cold Spring Harbor Perspectives in Medicine
- High-Density Lipoprotein Function, Dysfunction, and Reverse Cholesterol Transport
- (2012) Edward A. Fisher et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Novel Biological Functions of High-Density Lipoprotein Cholesterol
- (2012) Chieko Mineo et al. CIRCULATION RESEARCH
- Catalytic Versatility and Backups in Enzyme Active Sites: The Case of Serum Paraoxonase 1
- (2012) Moshe Ben-David et al. JOURNAL OF MOLECULAR BIOLOGY
- Pharmacological and Lifestyle Factors Modulating Serum Paraoxonase-1 Activity
- (2012) Jordi Camps et al. MINI-REVIEWS IN MEDICINAL CHEMISTRY
- Urinary 8-hydroxy-2′-deoxyguanosine level and plasma paraoxonase 1 activity with Alzheimer’s disease
- (2011) Oğuzhan Zengi et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Human nuclear clusterin mediates apoptosis by interacting with Bcl-XL through C-terminal coiled coil domain
- (2011) Nayoung Kim et al. JOURNAL OF CELLULAR PHYSIOLOGY
- LCAT, HDL Cholesterol and Ischemic Cardiovascular Disease: A Mendelian Randomization Study of HDL Cholesterol in 54,500 Individuals
- (2011) Christiane L. Haase et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Mechanisms underlying adverse effects of HDL on eNOS-activating pathways in patients with coronary artery disease
- (2011) Christian Besler et al. JOURNAL OF CLINICAL INVESTIGATION
- The extracellular chaperone clusterin sequesters oligomeric forms of the amyloid-β1−40 peptide
- (2011) Priyanka Narayan et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy
- (2011) NEW ENGLAND JOURNAL OF MEDICINE
- Biological activities of HDL subpopulations and their relevance to cardiovascular disease
- (2011) Laurent Camont et al. TRENDS IN MOLECULAR MEDICINE
- Association of Plasma Clusterin Concentration With Severity, Pathology, and Progression in Alzheimer Disease
- (2010) Madhav Thambisetty et al. ARCHIVES OF GENERAL PSYCHIATRY
- Association of Higher Levels of High-Density Lipoprotein Cholesterol in Elderly Individuals and Lower Risk of Late-Onset Alzheimer Disease
- (2010) Christiane Reitz et al. ARCHIVES OF NEUROLOGY
- Human PON1, a biomarker of risk of disease and exposure
- (2010) C.E. Furlong et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Immunohistochemical analysis of paraoxonases-1 and 3 in human atheromatous plaques
- (2010) Judit Marsillach et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- HDL-associated paraoxonase-1 can redistribute to cell membranes and influence sensitivity to oxidative stress
- (2010) Sara P. Deakin et al. FREE RADICAL BIOLOGY AND MEDICINE
- Astrocytic Aβ1-42 uptake is determined by Aβ-aggregation state and the presence of amyloid-associated proteins
- (2010) Henrietta M. Nielsen et al. GLIA
- Apolipoprotein A-I Deficiency Increases Cerebral Amyloid Angiopathy and Cognitive Deficits in APP/PS1ΔE9 Mice
- (2010) Iliya Lefterov et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Overexpression of Human Apolipoprotein A-I Preserves Cognitive Function and Attenuates Neuroinflammation and Cerebral Amyloid Angiopathy in a Mouse Model of Alzheimer Disease
- (2010) Terry L. Lewis et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Decreased paraoxonase-1 activity is associated with alterations of high-density lipoprotein particles in chronic liver impairment
- (2010) Judit Marsillach et al. Lipids in Health and Disease
- Decreased serum arylesterase activity in autism spectrum disorders
- (2010) Laura Gaita et al. PSYCHIATRY RESEARCH
- Inhibition of c-Jun N-terminal kinase increases apoE expression in vitro and in vivo
- (2009) Ana Pocivavsek et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Extracellular chaperones modulate the effects of Alzheimer’s patient cerebrospinal fluid on Aβ1-42 toxicity and uptake
- (2009) Justin J. Yerbury et al. CELL STRESS & CHAPERONES
- The paraoxonases: role in human diseases and methodological difficulties in measurement
- (2009) Jordi Camps et al. CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES
- Mechanism underlying apolipoprotein E (ApoE) isoform-dependent lipid efflux from neural cells in culture
- (2009) Hirohisa Minagawa et al. JOURNAL OF NEUROSCIENCE RESEARCH
- Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease
- (2009) Jean-Charles Lambert et al. NATURE GENETICS
- Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease
- (2009) Denise Harold et al. NATURE GENETICS
- Low HDL Cholesterol Is a Risk Factor for Deficit and Decline in Memory in Midlife
- (2008) Archana Singh-Manoux et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Macrophage paraoxonase 1 (PON1) binding sites
- (2008) Michal Efrat et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Immunohistochemical analysis of paraoxonases-1, 2, and 3 expression in normal mouse tissues
- (2008) Judit Marsillach et al. FREE RADICAL BIOLOGY AND MEDICINE
- Dominant Role of Paraoxonases in Inactivation of the Pseudomonas aeruginosa Quorum-Sensing Signal N-(3-Oxododecanoyl)-L-Homoserine Lactone
- (2008) J. F. Teiber et al. INFECTION AND IMMUNITY
- Human apolipoprotein A–I binds amyloid-β and prevents Aβ-induced neurotoxicity
- (2008) Andréa C. Paula-Lima et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Serum Paraoxonase Undergoes Inhibition and Proteolysis During Experimental Acute Pancreatitis
- (2008) Neus Franco-Pons et al. JOURNAL OF GASTROINTESTINAL SURGERY
- Paraoxonase 1 (PON1) organophosphate hydrolysis is not reduced in ALS
- (2008) A. -M. Wills et al. NEUROLOGY
- Paraoxonase 1 (PON1) status and substrate hydrolysis
- (2008) Rebecca J. Richter et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now